59 results on '"Sieper, Joachim"'
Search Results
2. Efficacy and safety of upadacitinib in patients with ankylosing spondylitis refractory to biologic therapy: 1-year results from the open-label extension of a phase III study
3. Geschichte der Biologikatherapie bei axialer Spondyloarthritis – Teil 2
4. Implementing an automated monitoring process in a digital, longitudinal observational cohort study
5. Deep learning for detection of radiographic sacroiliitis: achieving expert-level performance
6. The prevalence and impact of comorbidities on patients with axial spondyloarthritis: results from a nationwide population-based study
7. Treatment of Axial Spondyloarthritis: What Does the Future Hold?
8. The IL-23–IL-17 pathway as a therapeutic target in axial spondyloarthritis
9. Current Unmet Needs in Spondyloarthritis
10. Incorporation of the anteroposterior lumbar radiographs in the modified Stoke Ankylosing Spondylitis Spine Score improves detection of radiographic spinal progression in axial spondyloarthritis
11. An explorative study on deep profiling of peripheral leukocytes to identify predictors for responsiveness to anti-tumour necrosis factor alpha therapies in ankylosing spondylitis: natural killer cells in focus
12. Do ethnicity, degree of family relationship, and the spondyloarthritis subtype in affected relatives influence the association between a positive family history for spondyloarthritis and HLA-B27 carriership? Results from the worldwide ASAS cohort
13. Clinical and MRI remission in patients with nonradiographic axial spondyloarthritis who received long-term open-label adalimumab treatment: 3-year results of the ABILITY-1 trial
14. Relevance of structural damage in the sacroiliac joints for the functional status and spinal mobility in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort
15. Mechanism of New Bone Formation in Axial Spondyloarthritis
16. Serum levels of leptin and high molecular weight adiponectin are inversely associated with radiographic spinal progression in patients with ankylosing spondylitis: results from the ENRADAS trial
17. Synovial cell production of IL-26 induces bone mineralization in spondyloarthritis
18. A randomized, clinical trial to assess the relative efficacy and tolerability of two doses of etoricoxib versus naproxen in patients with ankylosing spondylitis
19. New evidence on the management of spondyloarthritis
20. Cartilage in facet joints of patients with ankylosing spondylitis (AS) shows signs of cartilage degeneration rather than chondrocyte hypertrophy: implications for joint remodeling in AS
21. In vivo pre-activation of monocytes in patients with axial spondyloarthritis
22. Axial spondyloarthritis
23. Good correlation between changes in objective and subjective signs of inflammation in patients with short- but not long duration of axial spondyloarthritis treated with tumor necrosis factor-blockers
24. Wenn die Wirbelsäule versteift
25. Treatment Challenges in Axial Spondylarthritis and Future Directions
26. Long-term outcome of patients with active ankylosing spondylitis with etanercept-sustained efficacy and safety after seven years
27. Intraarticular Application of Opioids versus Glucocorticoids versus Placebo in Gonarthritis
28. Referral strategies for early diagnosis of axial spondyloarthritis
29. Developments in therapies for spondyloarthritis
30. Impaired Peripheral Th1 CD4+ T Cell Response to Escherichia coli Proteins in Patients with Crohn’s Disease and Ankylosing Spondylitis
31. Relationship of bone mineral density with disease activity and functional ability in patients with ankylosing spondylitis: a cross-sectional study
32. New insights into therapy—TNF blockade and beyond
33. Analysis of IL-17+ cells in facet joints of patients with spondyloarthritis suggests that the innate immune pathway might be of greater relevance than the Th17-mediated adaptive immune response
34. Blockade of intra-articular adrenergic receptors increases analgesic demands for pain relief after knee surgery
35. Developments in the scientific and clinical understanding of the spondyloarthritides
36. Relevance of osteoproliferation as an outcome parameter in ankylosing spondylitis
37. Spondyloarthritis at the crossroads of imaging, pathology, and structural damage in the era of biologics
38. Infliximab therapy for patients with ankylosing spondylitis: on-demand or continuous treatment?
39. The human anti-IL-1β monoclonal antibody ACZ885 is effective in joint inflammation models in mice and in a proof-of-concept study in patients with rheumatoid arthritis
40. Serum levels of biomarkers of bone and cartilage destruction and new bone formation in different cohorts of patients with axial spondyloarthritis with and without tumor necrosis factor-alpha blocker treatment
41. The relationship between inflammation and new bone formation in patients with ankylosing spondylitis
42. Diagnosing early ankylosing spondylitis
43. Homologous high-throughput expression and purification of highly conserved E coli proteins
44. A case of axial undifferentiated spondyloarthritis diagnosis and management
45. Early diagnosis of spondyloarthritis
46. Frühdiagnose rheumatischer Erkrankungen—
47. Fluoroscopy-guided application of corticosteroids for local control of manubriosternal joint pain in patients with spondyloarthropathies
48. An elevated level of IL-10- and TGF?-secreting T cells, B cells and macrophages in the synovial membrane of patients with reactive arthritis compared to rheumatoid arthritis
49. Disease mechanisms in reactive arthritis
50. Etanercept
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.